Temporal Dynamics of GABA and Glx in the Visual Cortex. by Rideaux, Reuben
1 
 
Temporal dynamics of GABA and Glx in the visual cortex 
ABREVIATED TITLE: TEMPORAL METABOLITE DYNAMICS IN VISUAL CORTEX 
Reuben Rideaux 
Department of Psychology, Downing Street, University of Cambridge, CB2 3EB, UK  
reuben.rideaux@gmail.com 
 
Number of pages: 31 
Number of figures: 5 
Number of tables: 2 
Number of multimedia: 0 
Number of 3D models: 0 
Number of words (abstract): 218 
Number of word (introduction): 750 
Number of words (discussion): 1704 
Conflict of interest statement: The authors declare no competing interests. 
Acknowledgements: The work was supported by the Leverhulme Trust (ECF-2017-573) and 




Magnetic resonance spectroscopy (MRS) can be used in vivo to quantify neurometabolite 
concentration and provide evidence for the involvement of different neurotransmitter systems, 
e.g., inhibitory and excitatory, in sensory and cognitive processes. The relatively low signal-
to-noise of MRS measurements has shaped the types of questions that it has been used to 
address. In particular, temporal resolution is often sacrificed in MRS studies to achieve 
sufficient signal to produce a reliable estimate of neurometabolite concentration. Here we 
apply novel analyses with large datasets from human participants (both sexes) to reveal the 
dynamics of GABA+ and Glx in visual cortex while participants are at rest (with eyes closed) 
and compare this with changes in posterior cingulate cortex from a previously collected 
dataset (under different conditions). We find that the dynamic concentration of GABA+ and 
Glx in visual cortex drifts in opposite directions, that is, GABA+ decreases while Glx increases 
over time. Further, we find that in visual, but not posterior cingulate cortex, the concentration 
of GABA+ predicts that of Glx 120 s later, such that a change in GABA+ is correlated with a 
subsequent opposite change in Glx. Together, these results expose novel temporal trends 
and interdependencies of primary neurotransmitters in visual cortex. More broadly, we 





Using large datasets of magnetic resonance spectroscopy acquisitions from human 
participants, we develop novel analyses to investigate the temporal dynamics of 
neurometabolite concentration in visual cortex. We find that while participants are at rest, the 
concentration of GABA+ and Glx drifts in opposite directions, that is, GABA+ decreases while 
Glx increases over time. Further, we find that the concentration of GABA+ predicts that of Glx 
120 s later, such that a change in GABA+ is correlated with a subsequent opposite change in 




Magnetic resonance spectroscopy (MRS) can be used in vivo to measure the 
concentration of neurometabolites within the brain. The blood-oxygen-level-dependent signal 
measured using functional magnetic resonance imaging (fMRI) can provide evidence of neural 
activity; however, MRS can provide evidence that can be used to distinguish between different 
types of activity, e.g., excitatory and inhibitory. For the purpose of understanding neural 
mechanisms, identifying the involvement of neurotransmitter systems that support 
sensory/cognitive processes can be more informative than locating regions of neural 
representation. 
Previous work using MRS to understand the role of different neurotransmitters in 
normal brain function has focused on neurometabolite activity in visual cortex; in particular, 
the function of γ-aminobutyric acid (GABA) and Glutamate (Glu), the primary inhibitory and 
excitatory neurotransmitters in the central nervous system, respectively. A consistent finding 
from these studies is that Glu increases in visual cortex in response to visual stimulation, which 
has been interpreted as increased involvement of this neurotransmitter during processing of 
visual stimuli (Bednařík et al., 2018, 2015; Ip et al., 2017; Kurcyus et al., 2018; Lin et al., 2012; 
Mangia et al., 2007; Schaller et al., 2013). The findings relating to GABA have been less 
consistent. One study found less GABA in visual cortex during visual stimulation compared to 
baseline (Mekle et al., 2017), while other studies have not replicated this result (Bednařík et 
al., 2018, 2015; Kurcyus et al., 2018; Mangia et al., 2007; Schaller et al., 2013).  
The classic ‘static’ fMRS approach, i.e., comparing the average neurometabolite 
concentration during one experimental condition with another, has implicated GABA and Glu 
in visual processing. However, the information provided using this approach is severely 
limited. In particular, by reducing the measure of neurometabolite concentration to a single 
estimate averaged across a viewing condition, dynamic changes in concentration that occur 
under different states of visual processing are obscured. By contrast, establishing the temporal 
dynamics in neurometabolite concentration will reveal the timing and magnitude of change in 
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different neurotransmitters and novel relationships between neurotransmitters. This 
information is essential for a comprehensive understanding of the role of neurotransmitters in 
visual processing, but more broadly, it may inform our understanding of the balance between 
excitation and inhibition, which is thought to be a key factor in multiple neurological and 
psychiatric illnesses (Bradford, 1995; Kehrer et al., 2008; Rubenstein and Merzenich, 2003). 
The temporal resolution of MRS is highly restrained by the signal-to-noise ratio of 
measurements acquired using the technique. Although the duration that restricts the temporal 
resolution of MRS (i.e., the relaxation time) can be similar to that of fMRI (i.e., ~2 s), in order 
to yield a reliable measurement of neurometabolite concentration from within the brain, 
multiple transients must be combined to reach a sufficient signal-to-noise ratio (Mikkelsen et 
al., 2018). For example, it is common to combine between 200-300 transients (~10 min) to 
produce a single measure of neurometabolite concentration (Kurcyus et al., 2018; Rideaux 
and Welchman, 2018). Here we overcome the signal-to-noise limitation of MRS by applying 
temporal analyses of neurometabolite concentration to a large dataset of participants. We 
measure the dynamic concentration of GABA and Glx in visual cortex of participants while at 
rest (with closed eyes). We assess the regional specificity of temporal dynamics by comparing 
these results with data from posterior cingulate cortex (Mikkelsen et al., 2019, 2017). To 
observe the temporal dynamics of neurometabolites, we analyse the data in two ways. We 
first take a moving average of a ~6 min period, to reveal low frequency trends in the data 
(Chen et al., 2017; Rideaux et al., 2019). Next, using a new technique, we combine data 
across participants (rather than time), which allows us to track the concentration of 
neurometabolites with relatively high temporal resolution (12 sec) over a 13 min period. 
Based on previous empirical evidence, we may expect Glx to decrease and GABA to 
increase under conditions of no visual stimulation. By contrast, our analyses reveal the 
opposite pattern of results: Glx increases while GABA decreases (in visual, but not posterior 
cingulate cortex). These results are broadly consistent with findings from visual deprivation 
studies (Boroojerdi et al., 2000; Lunghi et al., 2015) and may provide a link between the 
conflicting results from MRS studies that use relatively short periods of visual deprivation 
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compared to those with longer periods. Further, we expose large changes in GABA and Glx, 
previously obscured by averaging over long durations and reveal a striking relationship 
between GABA and Glx in visual cortex: a change in GABA predicts the opposite change in 





Fifty-eight healthy participants with normal or corrected-to-normal vision participated 
in the experiment. The mean age was 24.4 yr (range, 19.4–40.5 yr; 31 women). Participants 
were screened for contra-indications to MRI prior to the experiment. All experiments were 
conducted in accordance with the ethical guidelines of the Declaration of Helsinki and were 
approved by the University ethics committee and all participants provided informed consent. 
Data collection 
Participants underwent a MR spectroscopic acquisition targeting visual cortex. During 
the acquisition, the lights in the room were turned off and participants were instructed to close 
their eyes. To compare these data with those measured from another brain region, we 
reanalysed previously gathered MR spectroscopic data targeting posterior cingulate cortex 
(Mikkelsen et al., 2019, 2017). 
Data acquisition 
Magnetic resonance scanning targeting visual cortex was conducted on a 3T Siemens 
Prisma equipped with a 32-channel head coil. Anatomical T1-weighted images were acquired 
for spectroscopic voxel placement with an ‘MP-RAGE’ sequence. For detection of GABA+  
and Glx, spectra were acquired using a MEGA-PRESS sequence (Mescher et al., 1998, 
1996): TE=68 ms, TR=3000 ms; 256 transients of 2048 data points were acquired in 13 min 
experiment time; a 14.28 ms Gaussian editing pulse was applied at 1.9 (ON) and 7.5 (OFF) 
ppm. Water suppression was achieved using variable power with optimized relaxation delays 
(VAPOR; Tkáč and Gruetter, 2005) and outer volume suppression. Automated shimming 
followed by manual shimming was conducted to achieve approximately 12 Hz water linewidth. 
 The “Big GABA” dataset comprises a collection of MRS datasets collected by different 
groups using the same parameters on GE, Phillips, and Siemens scanners. This dataset was 
acquired separately for a previous study and targeted posterior cingulate cortex; thus, here it 
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was reused as a region specificity control for the main visual cortex data. A detailed description 
of the data acquisitions for the Big GABA dataset can be found in Mikkelsen et al. (2019, 
2017). To summarize the procedure, magnetic resonance scanning targeting posterior 
cingulate cortex was conducted on 3T Siemens, GE, and Phillips scanners equipped with 8-, 
32-, or 64- channel head coils. Spectra were acquired using a MEGA-PRESS sequence: 
TE=68 ms, TR=2000 ms; 320 transients of either 2048 or 4096 data points were acquired in 
12 min experiment time; a 15 ms Gaussian editing pulse was applied at 1.9 (ON) and 7.5 
(OFF) ppm. Note that unlike the data collected in visual cortex, data collected in posterior 
cingulate cortex was not water-suppressed, which can negatively impact accurate 
quantification of other metabolites (e.g., sideband artifacts; see (Dong, 2015) for a review of 
issues relating to water suppression). The Big GABA dataset comprises sub-datasets 
collected by different research groups at different facilities. The following sub-datasets from 
the Big GABA dataset were used in the current study: G4, G5, G7, G8, P1, P3, P4, P5, P6, 
P7, P8, P9, P10, S1, S6, & S8; the letter in the notion refers to the scanner make and the 
number refers to the group that collected the data. Each sub-dataset (e.g., G4) comprises data 
from between 8-12 participants; in total there were data from 196 participants. With the 
exception of G1 and G6, this includes all the publicly available Big GABA datasets. We used 
the macromolecule unsuppressed transients from these datasets for closer comparison with 
visual cortex data, and we excluded data from G1 and G6 as these had fewer transients.  
 Spectra were acquired from a location targeting visual, i.e., V1/V2 (Fig. 1a), and 
posterior cingulate cortices (Fig. 1b); note, the posterior cingulate cortex data were acquired 
from the (previously described) publicly available Big GABA dataset. The voxel targeting visual 
cortex (3×3×2 cm) was placed medially in the occipital lobe; the lower face aligned with the 
cerebellar tentorium and positioned so to avoid including the sagittal sinus and to ensure it 
remained within the occipital lobe. The voxel targeting posterior cingulate cortex (3×3×3 cm) 
was positioned in the medial parietal lobe and rotated in the sagittal plane to align with a line 
connecting the genu and splenium of the corpus callosum. The coordinates of the voxel 
location were used to draw a mask on the anatomical T1-weighted image to calculate the 
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volume of grey matter, white matter, and cerebrospinal fluid within each voxel. Segmentation 
was performed using the Statistical Parametric Mapping toolbox for MATLAB (SPM12, 
http://www.fil.ion.ucl.ac.uk/spm/).  
Figure 1. Data acquisition. Representative MRS voxel placement for a) visual and b) posterior 
cingulate cortices on a T1-weighted structural image and probabilistic partial volume voxel maps 
following tissue segmentation for representative participant. Corresponding tissue proportions of grey 
matter (GM), white matter (WM) and cerebrospinal fluid (CSF) are shown. Average spectra across all 
subjects for c) visual and d) posterior cingulate cortices; number of subjects comprising each average 
spectrum is shown and grey shaded regions indicate standard deviation. Note the non-uniform 
baseline in (d), this resulted from the incomplete removal of the water peak (which was supressed in 
the visual but not the posterior cingulate cortex data) in the difference spectra; importantly, this non 
uniformity was modelled and removed during neurometabolite quantification.  
Data processing 
Spectral quantification was conducted in MATLAB using GANNET v3.1 (Edden et al., 
2014) and in-house scripts. Frequency, phase, area, and full width at half maximum (FWHM) 
parameters of the Creatine peak at 3.0 ppm were estimated by fitting a Lorentzian peak to the 
data and individual spectra with parameter estimates >3 standard deviations from the mean 
were omitted from further analysis; the remaining spectra were frequency and phase corrected 
using these parameters. To ensure spectral alignment between transients across time and 
participants, spectra were aligned such that the Cr peak was centered at the same frequency 
(3.0 ppm). Total creatine (tCr) and total N-acetylaspartate (tNAA) signal intensity were 
determined by fitting a single Lorentzian peak to the mean OFF spectra at 3.0 ppm and 2.0 
ppm, respectively. ON and OFF spectra were subtracted to produce the edited spectrum (Fig. 
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1c & d), from which GABA+ (GABA and co-edited macromolecules; 3 ppm) and Glx (a 
complex comprising Glu and Glutamine (Gln); 3.8 ppm) signal intensity were modelled on 
single- and double- Gaussian peaks, respectively. All neurometabolite signal intensities were 
calculated as the area of the fitted peak/s. 
Data in which the FWHM of any of the quantified neurometabolites (tCr, tNAA, GABA+, 
or Glx) was >3 standard deviations from the mean across each dataset (e.g., visual/posterior 
cingulate cortex) were omitted from further analysis. This resulted in omission of data from 
one participant in the visual cortex dataset and three participants in the posterior cingulate 
cortex dataset. 
Intensities of GABA+, Glx, and tNAA were normalized to the commonly used internal 
reference tCr (Jansen et al., 2006), yielding relative concentration values (i.e., GABA+:tCr, 
Glx:tCr, and tNAA:tCr; Fig. 1e). The tCr signal is acquired within the same MEGA-PRESS 
transients as the target neurometabolites. Thus, normalization of GABA+, Glx, and tNAA to 
tCr minimizes the influence of changes that occur during the acquisition which alter the entire 
spectrum, e.g., changes in signal strength, line width, chemical shift displacement, or dilution 
associated with changes in blood flow (Ip et al., 2017). For correlational analyses reported in 
Table 2 and static analyses shown in Figure 2, a cerebrospinal fluid tissue-correction (Harris 






where 𝐶𝑡𝑖𝑠𝑠𝑐𝑜𝑟𝑟  and 𝐶𝑚𝑒𝑎𝑠 are the  tissue-corrected and uncorrected neurometabolite 
concentrations (e.g., GABA+:tCr), respectively, and 𝑓𝑐𝑠𝑓  is the proportion of cerebrospinal fluid 
within the voxel. All other analyses report concentrations as a proportion of their initial 
magnitude, and thus do not require tissue correction. 
Low-resolution dynamic analysis 
For the low-resolution dynamic analysis of the visual cortex data, we used a sliding 
window (width, 128 transients; step size, 2 transients) to measure average neurometabolite 
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concentration as it changed over the course of the scan (256 transients/768 sec). This window 
size was based on previous work using this analysis on similar data (Rideaux et al., 2019).  
For the posterior cingulate cortex data (320 transients/640 sec), we matched the duration of 
the sliding window width to the that used for the visual cortex data by including more transients 
(width, 192 transients; step size, 2 transients).  
To determine if the average change in neurometabolite concentration was significantly 
different from zero, a two-sided t-test (alpha, .05) was performed at each time point. That is, 
for each brain region, each t-test included a single estimate from each participant, which 
corresponded to the participant’s change in neurometabolite concentration at that time. As 
multiple (65) tests were conducted for each neurometabolite, to reduce the likelihood of 
spurious significant differences in the time course, a cluster correction was applied at the 
group level, where time was the clustered dimension. Clusters were defined by the sum of 
their constituent t-values and compared to a null hypothesis distribution of clusters produced 
by shuffling the time labels (5000 permutations); positive and negative t-value clusters were 
treated separately. Clusters below the 95th percentile of the null hypothesis distribution were 
disregarded.  
High-resolution dynamic analysis 
The temporal resolution of MRS is severely limited by the signal-to-noise ratio of 
individual spectra. That is, to achieve the signal-to-noise ratio required to yield an accurate 
neurometabolite measurement, many individual spectra must be combined. In order to 
achieve sufficiently high signal in the low-resolution dynamic analysis, we combined multiple 
(128) spectra within the same subject. This method produces a dynamic trace for each 
participant; however, the smoothing produced by the sliding window approach may obscure 
both the true magnitude of metabolic change over time and dynamic changes occurring at 
higher frequencies. Thus, to achieve higher temporal resolution, we averaged individual ON 
and OFF spectra across participants to produce a single trace, with no smoothing, for each 
condition. As in the low temporal resolution analysis, we matched the temporal resolution 
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between datasets in the high temporal resolution analysis (12 s) by using a resolution of four 
and six transients in the visual and posterior cingulate cortices, respectively. 
To test for predictive relationships between GABA+ and Glx, we ran a cross-correlation 
analysis between the abovementioned high-resolution neurometabolite traces. We tested for 
relationships in both directions, that is, whether GABA+ concentration predicts Glx 
concentration and vice versa. The neurometabolite traces comprise a limited number of time 
points (visual cortex: 64, posterior cingulate cortex: 53) and there is an inverse relationship 
between the lag separating the neurometabolites and the number of time points included in 
the cross correlation analysis. This results in less reliable correlation values at lags close to 
the maximum duration of the neurometabolite traces due to insufficient sample sizes. To avoid 
these unreliable correlations, we only included lags with a minimum of 25 time points in the 
analysis (Bonett and Wright, 2000). This yielded a total of 40 correlations for each predictive 
direction between GABA+ and Glx in visual cortex and 29 for posterior cingulate cortex. Given 
that multiple tests were conducted, to reduce the likelihood of spurious significant correlation 
values in the cross-correlation analyses, a cluster correction was applied. Clusters were 
defined by the sum of their constituent t-values and compared to a null hypothesis distribution 
of clusters produced by shuffling the time labels (5000 permutations); positive and negative t-
value clusters were treated separately. Clusters below the 95 th percentile of the null hypothesis 
distribution were disregarded. 
Significance testing 
The significance of differences between data from different voxel locations was 
assessed using the independent samples t-test, and the significance of changes in 
neurometabolite concentration (from zero change) was assessed using the one-sample t-test; 
all tests were two-sided and used an alpha = .05. The normality assumption was tested with 
the Shapiro–Wilk test of normality. For data in which the assumption of normality was violated, 
significance was assessed using the Wilcoxon rank sum test. The significance of correlations 
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between neurometabolite concentrations was assessed using the Pearson linear correlation 




Spectra quality  
Table 1 shows the average FWHM, frequency drift and fit error for measurements 
taken from visual and posterior cingulate cortices. For each subject, the FWHM was calculated 
from the average spectra, i.e., spectra averaged across all (256/320) transients. Frequency 
drift was calculated as the standard deviation of the position of the Cr peak across individual 
OFF spectra, prior to alignment; the frequency drift values shown in Table 1 reflect the 
average standard deviation across participants. The fit error for GABA+, Glx, tNAA, and tCr 
were divided by the amplitude of their fitted peaks to produce normalized measures of 
uncertainty. The average fit error for each neurometabolite was relatively low (Mullins et al., 
2014; Table 1). Comparison between data from visual and posterior cingulate cortices 
revealed higher FWHM estimates for all quantified neurometabolites in visual cortex (GABA+, 
t(248)=16.80, P=8.4×10-43; Glx, z=9.24, P=9.4×10-20; tNAA, z=2.06, P=.040; tCr, z=7.07, 
P=1.5×10-12). This suggests that shimming may have been more effective in the posterior 
cingulate dataset; however, differences in voxel size, voxel tissue composition, and the 
number of transients collected may have contributed to this difference. We also found 
frequency drift (z=5.16, P=2.5×10-7), and fit error for GABA+ (z= 2.59, P=.010) and tNAA 
(z=4.89, P=1.0×10-6) were higher in the visual cortex dataset. By comparison, fit error was 
lower in visual cortex for Glx (z=-5.15, P=2.6×10-7) and tCr (z=-10.92, P=9.3×10-28). 
Table 1. Measures of spectral quality and fit error 
Location 
FWHM (Hz) Frequency drift 
(ppm std) 
Fit error (percent) 
GABA+ Glx tNAA tCr GABA+ Glx tNAA tCr 
VC 24.9±1.7 17.8±0.4 8.4±0.9 8.5±0.7 0.0088±0.0044 7.6±2.1 1.3±0.3 3.3±0.3 3.6±0.2 
PCC 20.5±1.7 16.8±0.7 8.2±0.8 7.6±0.7 0.0065±0.0061 6.9±1.7 2.1±1.5 3.1±1.3 4.5±0.5 
Note: values indicate across subject averages ± standard deviation. 
Static analysis 
  Figure 2 shows the distribution of grey matter, white matter, and cerebrospinal fluid 
voxel composition across participants for the visual and posterior cingulate cortex datasets. 
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We found that visual cortex voxels composed less grey matter (t(248)=7.53, P=9.3×10-13) and 
more cerebrospinal fluid (z=-6.27, P=3.6×10-10) than those from posterior cingulate cortex; no 
significant difference was found between white matter (t(248)=0.27, P=.787). We quantified the 
concentration of GABA+, Glx, and tNAA using the classic ‘static’ approach, in which all 
transients are averaged together to extract a single estimate.  After applying a cerebrospinal 
fluid tissue-correction, we compared the average neurometabolite concentration across 
participants between visual and posterior cingulate cortices. We found lower concentrations 
of GABA+:tCr (t(248)=-6.53, P=3.7×10-10) and Glx:tCr (z=-9.33, P=1.0×10-20) in visual cortex, 
but higher concentration of tNAA:tCr (t(248)=4.62, P=6.1×10-6; Fig. 2). 
Figure 2. Static analysis. Distribution of grey matter (GM), white matter (WM), and cerebrospinal 
fluid (CSF) voxel tissue proportions, and (GABA+, Glx, tNAA) neurometabolite concentrations across 
participants for visual and posterior cingulate cortices. Neurometabolite concentrations are tissue-
corrected and expressed as a ratio to tCr. Triangles indicate distribution means. 
Low-resolution temporal dynamics of GABA and Glx 
Using a sliding temporal window analysis, we quantified change in the concentration 
of GABA+ and Glx measured from MRS voxels targeting visual and posterior cingulate 
cortices over the course of 13 and 12 min periods, respectively. We found that in visual cortex, 
GABA+ significantly decreased (max difference=-5.0%, t(56)=-3.25, P=.002) while Glx 
significantly increased (max difference=2.7%, t(56)=3.74, P=4.4×10-4) over the course of the 
period (Fig. 3a). By comparison, we found that in posterior cingulate cortex there was no 
significant change in either GABA or Glx (Fig. 3b). The FWHM of the neurometabolite peaks 
indicate spectra from posterior cingulate cortex had better signal quality; further, this dataset 
contained more than three times as many participants as the visual cortex dataset. Thus, it 
seems unlikely that the neurometabolite drift we observed in visual cortex was also present in 
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posterior cingulate cortex, but that we failed to detect it because of poor signal quality or lack 
of statistical power. A more parsimonious explanation is that the neurometabolite drift in visual 
cortex was regionally specific. Given that we referenced GABA+ and Glx to tCr, a possible 
concern is that the changes in neurometabolite concentration observed in visual cortex reflect 
changes in tCr, as opposed to GABA+ or Glx. However, this is unlikely as we did not find any 
change in tNAA concentration, for either visual or posterior cingulate cortices, which was also 
referenced for tCr (Fig. 2a). 
Figure 3. Low-resolution temporal dynamics of neurometabolites in visual and posterior 
cingulate cortices. (a, top) Individual traces showing change in GABA+, Glx, and tNAA (all 
referenced to tCr) measured from an MRS voxel targeting visual cortex. (a, bottom) Same as (a, top), 
but averaged across participants. (b) Same as (a), but from a voxel targeting posterior cingulate 
cortex. Shaded regions indicate s.e.m. and horizontal coloured bars at the top and bottom of (a) 
indicate (cluster corrected) periods of significant difference from zero. Note, the scale of change was 
smaller for tNAA:tCr than the other two neurometabolites, so it is closely overlaid with the dashed 
‘zero’ line. 
We next assessed whether the fit error of the GABA+, Glx, tNAA, and tCr peaks 
changed over the course of the acquisition. For visual cortex, the were no significant changes 
in the fit error of the tNAA or tCr peaks. However, there were significant increases in fit error 
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for GABA+ between 360-394 s, and for Glx between 564-576 s.  A possible concern is that 
the changes we observed in the concentration of GABA+ and Glx in visual cortex were due to 
reduced neurometabolite quantification accuracy, i.e., increased fit error. To test this 
possibility, we assessed the inter-individual relationship between change in fit error and 
change in neurometabolite concentration, for GABA+ and Glx in visual cortex. We found no 
evidence for a relationship between fit error and concentration for either neurometabolite 
(GABA+, n=57, Pearson r=-.14, P=.308; Glx, n=57, Pearson r=.06, P=.676), indicating that 
change in quantification accuracy does not explain for the neurometabolite drift we observed 
in visual cortex. For posterior cingulate cortex, we found no dynamic change in fit error for any 
of the neurometabolites, with the exception of the GABA+ peak, where there was a window 
between 196-208 s in which the fit error was significantly reduced. 
Another possible concern is that changes observed in the difference spectra over time 
are related to scanner field drift due to gradient cooling (Lange et al., 2011) or participant 
motion (Bhattacharyya et al., 2007). In particular, if the scanner field drifts, the position of the 
editing pulse relative to the GABA and Glx peaks changes. This may change the efficiency 
with which the peaks are edited and thus their magnitude in the difference spectrum. As the 
frequency drift of the visual cortex spectra was higher than in posterior cingulate cortex, where 
we did not observe any change in neurometabolite concentration, this may account for the 
changes in neurometabolite concentration observed in visual cortex. As a test of this 
possibility, we measured the tNAA trough in the difference spectra using an inverse 
Lorentzian. Like the magnitude of the GABA+ and Glx peaks, the magnitude of the tNAA 
trough reflects the efficiency of the editing pulse. Thus, if scanner drift is responsible for 
changes in the magnitude of the GABA+ or Glx peaks, we would expect to see corresponding 
changes in the amplitude of the edited tNAA trough. However, we found no evidence for 
change in the amplitude of the edited tNAA trough over time. As a further test of this possibility, 
we assessed whether there was an inter-individual relationship between the degree of 
frequency drift and change in either GABA+ or Glx. If scanner drift produced the change in 
neurometabolite concentration we observed in visual cortex, we would expect these measures 
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to be positively correlated. By contrast, we found no relationship between frequency drift and 
either change in GABA+ (n=57, Pearson r=-.10, P=.457) or Glx (n=57, Pearson r=.06, 
P=.662). These results indicate that scanner drift did not contribute to the changes in 
neurometabolite concentration. 
Correlational analyses of static and low temporal resolution measurements 
For each voxel location, we assessed whether there were inter-individual relationships 
between different static neurometabolite concentrations or changes in concentration. For 
static measurements, we averaged across all 256/320 transients. The results of the analysis 
are shown in Table 2. For static neurometabolite concentrations, we found a positive 
relationship between Glx and tNAA measured from visual and posterior cingulate cortices. We 
also found a positive correlation between GABA+ and tNAA in visual cortex, and between 
GABA+ and Glx in posterior cingulate cortex. By contrast, the only relationship between 




Table 2. Correlation coefficients between neurometabolites measured from visual and 
posterior cingulate cortices 







VC -0.16 0.33* 0.33* 0.06 0.10 -0.17 
PCC 0.25*** 0.50*** 0.17* 0.03 -0.18* 0.04 
Note: Correlation coefficients are Pearson linear partial coefficients after controlling for the common reference 
neurometabolite tCr; VC and PCC denote visual and posterior cingulate cortices; all neurometabolites are 
referenced to tCr and tissue-corrected; single and triple asterisks indicate P<.05 and P<.001, respectively. 
High-resolution temporal dynamics of GABA and Glx 
To assess high temporal resolution dynamics of neurometabolites, we next combined 
transients across subjects, rather than across time. In visual cortex, we found change in 
GABA+, relative from the first measurement, was primarily negative and ranged from ±15% 
from the average concentration, while change in Glx was primarily positive and ranged from 
±10% (Fig. 4a). These results are consistent with those from the previous analysis, except the 
higher temporal resolution obtained with the current approach revealed considerably larger 
changes in neurometabolite concentration than the previous estimates, which were likely 
obscured by smoothing measurements across the temporal window. In posterior cingulate 
cortex, we found that change in both GABA+ and Glx was primarily negative, and similar in 




Figure 4. High-resolution temporal dynamics of neurometabolites in visual and posterior 
cingulate cortices. Change in GABA+ and Glx concentration, proportional to the average, measured 
from voxels targeting (a) visual and (b) posterior cingulate cortices. Semi-transparent lines indicate 
raw concentration estimates; for illustrational purposes, opaque lines indicate data smoothed using a 
window of eight time points. (c-d) Cross-correlations between GABA+ and Glx concentration 
measured from voxels targeting (c) visual and (d) posterior cingulate cortices. Lag values indicate the 
duration between when the GABA+ measurements were acquired and the Glx measurements were 
acquired. Correlations at negative lags indicate GABA+ concentration predicts Glx concentration and 
correlations at positive lags indicate Glx predicts GABA+. Vertical lines indicate 95% confidence 
intervals; cluster-corrected correlations that are significantly different than zero are highlighted in 
green. All values are referenced to tCr. 
While GABA and Glu are thought to support opposing mechanisms in the central 
nervous system, i.e., inhibition and excitation, it seems reasonable to expect interactions 
between GABA and Glx, which comprises both Glu and Gln. For example, Gln is a primary 
source of GABA synthesis (Patel et al., 2001; Paulsen et al., 1988; Rae et al., 2003). Indeed, 
we found that the static concentration of GABA+ and Glx were positively related in posterior 
cingulate cortex. However, we found no evidence for a relationship between the overall 
changes in these neurometabolites in either the visual or posterior cingulate cortices (Table 
2). One reason for this may be that the relationship between these neurometabolites may only 
be observed at a high temporal resolution, but not averaged when across a 6 min period. To 
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test this hypothesis, we used the high-resolution neurometabolite measurements to perform 
cross-correlation analyses on GABA+ and Glx concentration.  
For visual cortex, we found that the concentration of GABA+ predicted that of Glx 
between 108-132 sec later (n(time points)=[55,54,53], Pearson r=[-.36,-.31,-.39], 
P=[.008,.024,.004]; Fig. 4c). This relationship was negative, that is, a positive/negative 
change in GABA+ predicted a later change in Glx in the opposite direction. By contrast, we 
found no periods of latency in which Glx predicted the concentration of GABA+. For posterior 
cingulate cortex, we found no periods of latency in which there was a significant relationship 
between GABA+ and Glx (Fig. 4d). 
A possible concern is that the relationship between GABA+ and Glx was the influenced 
by their common reference neurometabolite (tCr). In particular, as both GABA+ and Glx were 
referenced to tCr, the relationship between them could be explained by an autocorrelation in 
the concentration tCr. However, we found the same pattern of results when tNAA, rather than 
tCr, was used as a reference neurometabolite (Fig. 5a). Another possible concern with this 
new analysis is that the signal-to-noise ratio is insufficient to yield valid measurements, e.g., 
due to reduced neurometabolite quantification accuracy. To assess the validity of the 
measurements, we compared the average FWHM and fit error of peaks produced in the high-
resolution analysis with those produce in the low-resolution analysis. For visual cortex, we 
found no evidence for a difference in FWHM for any of the target neurometabolites (GABA+, 
z=-0.06, P=.948; Glx, t(119)=-5.08, P=1.4×10-6; tCr, z=-1.10, P=.270). By comparison, fit error 
was lower for all target neurometabolites (GABA+, z=2.38, P=.017; Glx, z=4.21, P=2.5×10-5; 
tCr t(119)=2.24, P=.027) modelled in the high-resolution analysis. Similarly, for posterior 
cingulate cortex, we found no evidence for a difference in either FWHM (GABA+, z=1.62, 
P=.105; Glx, t(119)=1.76, P=.080; tCr, z=1.71, P=.087); however, while we found no evidence 
for a difference in fit error for GABA (z=1.32, P=.187) and Glx (z=-0.55, P=.581), fit error was 
higher for tCr (z=-2.34, P=.019) in the high-resolution analysis. With the exception of fit error 
of the tCr peak in posterior cingulate cortex, these results support the validity of the signal 
strength and quantification accuracy in the high-resolution analysis.  
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To further assess the validity of the measurements, we attempted to reproduce the 
results from the low-resolution analysis by applying a sliding window to the high-resolution 
neurometabolite trace. If the high-resolution measurements are valid, we would expect to find 
correspondence between the average results from the low-resolution analysis and those 
produced by applying a sliding window to the high-resolution measurements. For visual cortex, 
we found a high correspondence between the measurements produced by the two analyses 
for both GABA+ (n=33, Pearson r=.995, P=3.9×10-33; Fig. 5b, top) and Glx (n=33, Pearson 
r=.995, P=5.5×10-32). These results further validate the results of the high-resolution analysis 
in visual cortex. For posterior cingulate cortex, we found a correspondence between GABA+ 
measurements (n=22, Pearson r=.655, P=9.3×10-4; Fig. 5b, bottom), but not Glx 
measurements (n=22, Pearson r=.182, P=0.418). The weaker correspondence for data from 
posterior cingulate cortex may indicate that the measurements produced by the high-
resolution analysis in this region are less reliable. However, it is also likely because there was 
less variability in neurometabolite concentration in the low-resolution analysis of posterior 
cingulate cortex; thus, unlike in visual cortex, there may be insufficient variability to cross 
validate between the two measurements.  
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Figure 5. Controls for high-resolution analyses. (a) Cross-correlations between GABA+ and Glx, 
referenced to tNAA, measured from voxels targeting visual cortex. Vertical lines indicate 95% 
confidence intervals; cluster-corrected correlations that are significantly different than zero are 
highlighted in green, correlations at negative lags indicate GABA+ predicts Glx and correlations at 
positive lags indicate Glx predicts GABA+. (b) Comparison between results from sliding window 
method used in the low temporal resolution analysis (dashed lines) and sliding window applied to 





MRS can be used in vivo to quantify neurometabolite concentration and provide 
evidence for the involvement of different neurotransmitter systems, e.g., inhibitory and 
excitatory, in sensory and cognitive processes. In MRS studies, temporal resolution is typically 
sacrificed to achieve sufficient a signal-to-noise ratio to produce a reliable estimate of 
neurometabolite concentration. Here we use novel analyses with large datasets to reveal the 
dynamics of GABA+ and Glx in visual and posterior cingulate cortices. We use a sliding 
window approach to show that when participants are at rest with their eyes closed, the 
concentration of GABA+ and Glx in visual cortex drifts in opposite directions, that is, GABA+ 
decreases while Glx increases over time. We then use a new method of combining MRS 
measurements across subjects, as opposed to time, to produce a high temporal resolution 
index of neurometabolite concentration. Using this approach, we find that in visual cortex, a 
change in the concentration of GABA+ predicts the opposite change in Glx ~120 sec later, 
e.g., an increase in GABA+ predicts a later reduction in Glx. 
Dynamic response of GABA and Glx in visual cortex 
Several studies have investigated GABA and/or Glx/Glu concentration in visual cortex 
in response to different viewing conditions. Mekle et al. (2017) found a ~5% reduction in GABA 
concentration in response to visual stimulation. By contrast, while Kurcyus et al. (2018) 
reported that GABA was 16% lower when participants had their eyes open with no visual 
stimulation compared to when closed, they, like others (Bednařík et al., 2018, 2015; Mangia 
et al., 2007; Schaller et al., 2013), found no evidence for a difference in GABA in response to 
visual stimulation. Based on these somewhat inconsistent findings, one may infer that visual 
stimulation, or merely having the eyes open, leads to a reduction in the concentration of GABA 
in visual cortex. Extending this rationale, one could predict that closing the eyes should 
produce an increase in GABA. By contrast, we found the opposite result: during a 13 min 
period of resting in which participants’ eyes were closed, the concentration of GABA+ in visual 
cortex reduced on average by 5%. These results are consistent with previous work showing 
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that monocular deprivation leads to reduced GABA concentration (~8%) in visual cortex, but 
not posterior cingulate cortex, relative a pre-deprivation baseline measurement (Lunghi et al., 
2015). Thus, our finding that GABA is reduced when both eyes are closed may indicate that 
visual deprivation, either monocular or binocular, evokes a reduction in the concentration of 
GABA in visual cortex. 
 Previous observations of Glu concentration in visual cortex have been more 
consistent; several studies have shown Glx/Glu concentration increases (2-4%) in response 
to visual stimulation (Bednařík et al., 2018, 2015; Ip et al., 2017; Kurcyus et al., 2018; Lin et 
al., 2012; Mangia et al., 2007; Schaller et al., 2013). By contrast, here we found Glx increased 
when participants’ eyes were closed. Increased Glu in visual cortex, evoked by visual 
stimulation, has been linked to increased blood-oxygenation level dependent responses (Ip et 
al., 2017). Here we measured Glx, a complex comprising Glu and Gln, and previous 7T MRS 
work suggests that visual stimulation evoked changes in Glu, but not Gln, in visual cortex 
(Bednařík et al., 2018, 2015; Schaller et al., 2013). It is possible that the increase in Glx we 
found here, which occurred in the absence of visual stimulation, was driven by an alternative 
mechanism, one that is unrelated to BOLD activity and/or reflects changes in Gln rather than 
Glu. More work is needed it disambiguate changes in neurometabolite concentration that 
occur in visual cortex at different time scales and under different viewing conditions. For 
instance, future work could combine fMRI and MRS measurements to test whether the 
phenomenon observed here is related to BOLD activity (Ip et al., 2017). Additionally, future 
work could use a within-subject design to compare different voxel locations, and separately 
assess Glu and Gln concentration drift. 
Although the average concentration of GABA+ and Glx drifts in opposing directions, 
there were some participants who showed the opposite change in neurometabolite drift. One 
possible explanation for this is that the concentration of these neurometabolites oscillates at 
a relatively slow frequency (e.g., wavelength = 15 min), and entering a state of rest (with eyes 
closed) introduces the linear trend of neurometabolite concentration change indicated by the 
average, which is summed with the larger oscillatory changes. If such oscillatory behaviour 
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was occurring, it would be unlikely to be detected in the high-resolution analysis, as 
troughs/peaks would be obscured by phase differences between participants. Another 
possible explanation for the variability between participants is that it relates to their state of 
wakefulness during the scan. Although subjects reported not falling asleep, it seems likely that 
some may have been more alert than others during the scan, and this may be related to the 
concentration drift observed in visual cortex. We do not have the data to examine this 
possibility; however, future work could concurrently collect metabolite concentration and a 
physiological marker of wakefulness, e.g., EEG, to assess this possibility. 
Continuous unidirectional neurometabolite drift is not sustainable, i.e., neurometabolite 
concentration must maintain some degree of homeostasis. Thus, it seems likely that the 
change in concentration induced by resting only continues for a fixed period of time, before 
stabilising and possibly returning to ‘baseline’ levels. Indeed, this appeared to occur for Glx, 
where there is no additional increase after ~500 s, and the decrease is GABA+ appears to 
lessen after 400 s. Future work is needed to further understand dynamic neurometabolite 
activity over longer periods of time. 
To produce a high temporal resolution measure of neurometabolite concentrations, we 
applied a novel approach in which we combined MRS transients across subjects, rather than 
time. This approach yields a single measurement of neurometabolite concentration as a 
function of time; thus, we cannot test the statistical significance of the changes observed. 
However, it is reasonable to assume that the changes estimated using sliding window or static 
approaches underestimate the true magnitude of change, due to averaging. The 
measurements produced here by combining transients across subjects provide an indication 
of the true magnitude of change in GABA+ and Glx during the scan: up to 30% for GABA+ 
and 20% for Glx. 
Dynamic relationship between GABA and Glx 
A common finding among studies of GABA and Glu in visual cortex is that these 
neurometabolites change in opposite directions, and not in the same direction (Kurcyus et al., 
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2018; Mekle et al., 2017; Rideaux et al., 2019). This pattern would suggest an 
interdependency between the two neurometabolites. Given that Gln is a primary source of 
GABA synthesis (Patel et al., 2001; Paulsen et al., 1988; Rae et al., 2003), one may expect 
that a change in the concentration of GABA may result in a corresponding change in Glx, or 
vice versa. In line with this, our high temporal resolution analysis of the data revealed a striking 
cross-correlation between these neurometabolites in visual cortex. Specifically, we found that 
the concentration of GABA+ predicts the concentration of Glx ~120 sec later. This relationship, 
which accounts for up to ~20% of the variance of Glx, is obscured by conventional approaches 
of MRS analysis; indeed, we found no evidence for a relationship between the overall change 
in GABA+ and Glx. 
A limitation of MRS is that it measures the total concentration of neurometabolites 
within a localized region and cannot distinguish between intracellular and extracellular pools 
of GABA. It is generally thought that intracellular vesicular GABA drives neurotransmission 
(Belelli et al., 2009), whereas extracellular GABA maintains tonic cortical inhibition (Martin and 
Rimvall, 1993). Synthesis of intracellular GABA from Gln via the GABA-Gln cycle occurs on 
the scale of milliseconds, so it seems unlikely that this metabolic association could explain the 
predictive relationship between GABA and Glx concentration 120 sec later. Instead, this 
relationship may reflect changes in the level of extracellular GABA, followed by relatively 
sluggish changes in the concentration of Glu to maintain the balance of inhibition and 
excitation. 
Clinical relevance 
 An imbalance between excitation and inhibition, in particular between Glu and GABA, 
is thought to underlie a range of neurological and psychiatric disorders including epilepsy 
(Bradford, 1995; Olsen and Avoli, 1997), autism (Chao et al., 2010; Markram and Markram, 
2010; Rubenstein and Merzenich, 2003; Vattikuti and Chow, 2010), and schizophrenia (Kehrer 
et al., 2008). Here we demonstrated that it is possible to use MRS to measure changes in 
neurometabolite concentration at relatively high temporal resolution, and in the process of 
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doing so, we revealed a novel predictive relationship between GABA+ and Glx in visual cortex 
of healthy human participants. More broadly, this method could be used to reveal other trends 
and relationships between neurometabolites that have thus far been obscured by the classic 
‘static’ measurement approach. Uncovering the dynamics of the excitation-inhibition balance 
in this way may be instrumental in understanding unhealthy brain function. However, a caveat 
to this approach is that it requires a relatively large amount of MRS data. Here, we used a 
large number of subjects to meet this requirement; however, this may not be appropriate for 
clinical studies in which suitable subjects are more difficult to recruit. In this case, a modified 
event-related version of the method used here may be effective (Branzoli et al., 2013). That 
is, events (e.g., a 2 min stimulus presentation) could be repeated multiple times over a long 
period, separated by baseline resting intervals. Transients could then be aligned according to 
the time course of the event and averaged together. This would provide the same signal-to-
noise improvement reached in the current study, while requiring fewer participants. 
Conclusion 
 The relatively low signal-to-noise of MRS measurements has shaped the types of 
questions that the technique has been used to address. Here we overcome this limitation by 
combining data from large cohorts to examine the dynamics of GABA and Glx concentration 
in visual cortex. Through use of existing and novel analyses, we reveal opposing dynamic 
shifts in GABA and Glx in visual cortex while participants are at rest. Further, we demonstrate 
a predictive relationship between GABA and Glx in visual cortex. This study exposes temporal 
trends of primary neurotransmitters in visual cortex, and more generally, these findings 
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